Cargando…

Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer

Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer characterized by metastasis, drug resistance and high rates of recurrence. With a lack or targeted therapies, TNBC is challenging to treat and carries a poor prognosis. Patients with TNBC tumors expressing high levels of ERK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gagliardi, Maria, Pitner, Mary Kathryn, Park, Jihyun, Xie, Xuemei, Saso, Hitomi, Larson, Richard A., Sammons, Rachel M., Chen, Huiqin, Wei, Caimiao, Masuda, Hiroko, Chauhan, Gaurav, Kondo, Kimie, Tripathy, Debu, Ueno, Naoto T., Dalby, Kevin N., Debeb, Bisrat G., Bartholomeusz, Chandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244517/ https://www.ncbi.nlm.nih.gov/pubmed/32444778 http://dx.doi.org/10.1038/s41598-020-65250-3

Ejemplares similares

Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer
por: Xie, Xuemei, et al.
Publicado: (2023)

Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer
por: Hu, Xiaoding, et al.
Publicado: (2021)

NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer
por: Villodre, Emilly S., et al.
Publicado: (2020)

Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt
por: Bartholomeusz, Chandra, et al.
Publicado: (2011)

Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression
por: Park, Jihyun, et al.
Publicado: (2021)

JNK Signaling in Stem Cell Self-Renewal and Differentiation
por: Semba, Takashi, et al.
Publicado: (2020)

Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA molecular subtypes
por: Masuda, Hiroko, et al.
Publicado: (2017)

Modulating multi-functional ERK complexes by covalent targeting of a recruitment site in vivo
por: Kaoud, Tamer S., et al.
Publicado: (2019)

Optogenetic actuator – ERK biosensor circuits identify MAPK network nodes that shape ERK dynamics
por: Dessauges, Coralie, et al.
Publicado: (2022)

Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism
por: Debeb, Bisrat G., et al.
Publicado: (2016)

Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion
por: Villodre, Emilly S., et al.
Publicado: (2021)

S-nitrosylation of ERK inhibits ERK phosphorylation and induces apoptosis
por: Feng, Xiujing, et al.
Publicado: (2013)

Isoform-Specific Roles of ERK1 and ERK2 in Arteriogenesis
por: Ricard, Nicolas, et al.
Publicado: (2019)

ERK1 and ERK2 present functional redundancy in tetrapods despite higher evolution rate of ERK1
por: Buscà, Roser, et al.
Publicado: (2015)

Phosphorylation of ERK5 on Thr732 Is Associated with ERK5 Nuclear Localization and ERK5-Dependent Transcription
por: Honda, Takuto, et al.
Publicado: (2015)

EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer
por: Wang, Xiaoping, et al.
Publicado: (2017)

Specifically targeting ERK1 or ERK2 kills Melanoma cells
por: Qin, Jianzhong, et al.
Publicado: (2012)

The role of ERK-1 and ERK-2 gene polymorphisms in PCOS pathogenesis
por: Guney, Gurhan, et al.
Publicado: (2022)

ERK1/2 inhibitors act as monovalent degraders inducing ubiquitylation and proteasome-dependent turnover of ERK2, but not ERK1
por: Balmanno, Kathryn, et al.
Publicado: (2023)

Time encoding by ERKs
por: Wells, William A.
Publicado: (2005)

Distinct functions for ERKs?
por: Lloyd, Alison C
Publicado: (2006)

Erk in Kidney Diseases
por: Feliers, Denis, et al.
Publicado: (2011)

Irisin ERKs the Fat
por: Wu, Jun, et al.
Publicado: (2014)

MAPK-ERK Pathway
por: Park, Jong-In
Publicado: (2023)

Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models
por: Wolfe, Adam R., et al.
Publicado: (2016)

The N-Terminal Domain of ERK1 Accounts for the Functional Differences with ERK2
por: Marchi, Matilde, et al.
Publicado: (2008)

Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin
por: Shukla, Arti, et al.
Publicado: (2010)

ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?
por: Buscà, Roser, et al.
Publicado: (2016)

Structural and Dynamic Features of F-recruitment Site Driven Substrate Phosphorylation by ERK2
por: Piserchio, Andrea, et al.
Publicado: (2015)

The MAPK/ERK channel capacity exceeds 6 bit/hour
por: Nałęcz-Jawecki, Paweł, et al.
Publicado: (2023)

LPS-Induced G-CSF Expression in Macrophages Is Mediated by ERK2, but Not ERK1
por: Chang, Shwu-Fen, et al.
Publicado: (2015)

Regulation of atypical MAP kinases ERK3 and ERK4 by the phosphatase DUSP2
por: Perander, Maria, et al.
Publicado: (2017)

Validation of commercial ERK antibodies against the ERK orthologue of the scleractinian coral Stylophora pistillata
por: Courtial, Lucile, et al.
Publicado: (2017)

How to Steer and Control ERK and the ERK Signaling Cascade Exemplified by Looking at Cardiac Insufficiency
por: Breitenbach, Tim, et al.
Publicado: (2019)

Somatic mutations, clinicopathologic characteristics, and survival in patients with untreated breast cancer with bone-only and non-bone sites of first metastasis
por: Kono, Miho, et al.
Publicado: (2018)

Erratum: Structural and Dynamic Features of F-recruitment Site Driven Substrate Phosphorylation by ERK2
por: Piserchio, Andrea, et al.
Publicado: (2015)

Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model
por: Lacerda, Lara, et al.
Publicado: (2015)

Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines
por: Xie, Xuemei, et al.
Publicado: (2023)

ERK5 is activated by oncogenic BRAF and promotes melanoma growth
por: Tusa, Ignazia, et al.
Publicado: (2018)

HDM2 ERKs PCNA
por: Nguyen, Hai Dang, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4hqimhjgeaque9kfut8q3snv4f